Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Myriad Pharmaceuticals, Inc. | 545,245 | reported | 18 Jun 2012 | tx 58+512,279−407 |
| QLT INC/BC | 242,433 | reported | 15 May 2017 | tx 46+2,051,548−76,092 |
| Orchestra BioMed Holdings, Inc. | 118,118 | reported | 18 May 2026 | tx 19+302,796−11,700 |
| LIGAND PHARMACEUTICALS INC | 71,323 | reported | 08 Dec 2025 | tx 148+309,714−293,895 |
| LIFECORE BIOMEDICAL, INC. \DE\ | 44,060 | reported | 15 Jul 2025 | tx 2+44,060 |
| IMMUNOMEDICS INC | 22,500 | reported | 08 Jan 2017 | tx 1+22,500 |
| Vaxart, Inc. | 20,000 | reported | 25 May 2011 | tx 88+135,000−1,103,374 |
| Anebulo Pharmaceuticals, Inc. | 4,964 | reported | 04 Apr 2025 | tx 5+104,538 |
| MERRIMACK PHARMACEUTICALS INC | 3,802 | reported | 16 Jul 2019 | tx 4+3,802 |
| Aralez Pharmaceuticals Inc. | 0 | reported | 23 May 2017 | tx 8+340,929−388,685 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | PURCHASE | Orchestra BioMed Holdings, Inc. | 665 | 3.75 USD | |
| 15 May 2026 | PURCHASE | Orchestra BioMed Holdings, Inc. | 8,971 | 3.90 USD | |
| 08 Dec 2025 | EXERCISE | LIGAND PHARMACEUTICALS INC | 2,034 | 69.51 USD | |
| 08 Dec 2025 | EXERCISE | LIGAND PHARMACEUTICALS INC | 2,034 | 0.00 USD | deriv |
| 23 Sept 2025 | SALE | LIGAND PHARMACEUTICALS INC | 4,418 | 170.41 USD | |
| 23 Sept 2025 | SALE | LIGAND PHARMACEUTICALS INC | 954 | 171.92 USD | |
| 23 Sept 2025 | SALE | LIGAND PHARMACEUTICALS INC | 4,628 | 170.96 USD | |
| 19 Sept 2025 | PURCHASE | Orchestra BioMed Holdings, Inc. | 1,000 | 2.45 USD | first after silence |
| 07 Aug 2025 | GRANT_AWARD | Orchestra BioMed Holdings, Inc. | 15,000 | 0.00 USD | |
| 15 Jul 2025 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 19,506 | — | |
| 24 Jun 2025 | GRANT_AWARD | Orchestra BioMed Holdings, Inc. | 12,422 | 0.00 USD | |
| 24 Jun 2025 | GRANT_AWARD | Orchestra BioMed Holdings, Inc. | 36,797 | 0.00 USD | deriv |
| 06 Jun 2025 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1,209 | 0.00 USD | |
| 06 Jun 2025 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 5,783 | 0.00 USD | deriv |
| 04 Apr 2025 | GRANT_AWARD | Anebulo Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 04 Apr 2025 | GRANT_AWARD | Anebulo Pharmaceuticals, Inc. | 4,964 | 0.00 USD | deriv |
| 27 Dec 2024 | EXERCISE | Orchestra BioMed Holdings, Inc. | 11,700 | 4.30 USD | |
| 27 Dec 2024 | EXERCISE | Orchestra BioMed Holdings, Inc. | 11,700 | 0.00 USD | deriv |
| 19 Aug 2024 | GRANT_AWARD | LIFECORE BIOMEDICAL, INC. \DE\ | 24,554 | — | |
| 20 Jun 2024 | GRANT_AWARD | Orchestra BioMed Holdings, Inc. | 5,376 | 0.00 USD | |
| 20 Jun 2024 | GRANT_AWARD | Orchestra BioMed Holdings, Inc. | 17,068 | 0.00 USD | deriv |
| 14 Jun 2024 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1,252 | 0.00 USD | |
| 14 Jun 2024 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 5,444 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Anebulo Pharmaceuticals, Inc. | 41,667 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Anebulo Pharmaceuticals, Inc. | 2,482 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 19 Sept 2025.